Literature DB >> 24370142

Value of dual-phase (99m)Tc-sestamibi scintigraphy with neck and thoracic SPECT/CT in secondary hyperparathyroidism.

Jigang Yang1, Ruirui Hao, Leilei Yuan, Chunlin Li, Jue Yan, Lishi Zhen.   

Abstract

OBJECTIVE: Surgical intervention in the form of parathyroidectomy is generally considered only for severe secondary hyperparathyroidism (sHPT). However, correct location of the parathyroid glands before parathyroidectomy is a challenge. The purpose of this study was to compare the diagnostic value of early and delayed phase (99m)Tc-sestamibi SPECT/CT in the detection of parathyroid tissue to guide operative treatment of patients with sHPT. SUBJECTS AND METHODS: Eighty patients with sHPT who were undergoing hemodialysis were evaluated preoperatively with dual-phase (99m)Tc-sestamibi SPECT/CT parathyroid scintigraphy to locate parathyroid tissue before parathyroidectomy. The scintigraphic results were classified as positive or negative. The accuracy of (99m)Tc sestamibi early and delayed phase SPECT/CT scintigraphy was determined.
RESULTS: Early phase (99m)Tc-sestamibi SPECT/CT depicted 3.57 parathyroid glands (PTGs) and delayed phase (99m)Tc-sestamibi SPECT/CT depicted 3.55 PTGs per study. The specificity of both early and delayed phase (99m)Tc-sestamibi SPECT/CT in detecting PTGs was 100%. The (99m)Tc-sestamibi SPECT/CT images of 7 of 80 patients showed positive findings in the delayed phase and negative findings in the early phase. The (99m)Tc-sestamibi SPECT/CT images of 6 of 80 patients showed positive findings in the early phase and negative findings in the delayed phase.
CONCLUSION: The results of our study indicate that both early and delayed phase (99m)Tc-sestamibi SPECT/CT should be performed in the preoperative evaluation of hemodialysis patients with sHPT due to chronic kidney disease. Performance of both early and delayed phase (99m)Tc-sestamibi SPECT/CT did not increase the radiation dose compared with the use of only the early or the delayed phase.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24370142     DOI: 10.2214/AJR.13.11053

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  NaF18-PET/CT Imaging of Secondary Hyperparathyroidism.

Authors:  Aung Zaw Win; Carina Mari Aparici
Journal:  Nucl Med Mol Imaging       Date:  2015-01-23

2.  Diagnosis performance of 99mTc-MIBI and multimodality imaging for hyperparathyroidism.

Authors:  Jun Zhou; Di-Yu Lu; Liang Xia; Xiao-Jie Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

Review 3.  Surgical management of secondary hyperparathyroidism: how to effectively reduce recurrence at the time of primary surgery.

Authors:  D Xu; Y Yin; L Hou; W Dai
Journal:  J Endocrinol Invest       Date:  2015-11-30       Impact factor: 4.256

4.  Is dual-phase SPECT/CT with 99mTc-sestamibi better than single-phase SPECT/CT for lesion localization in patients with hyperparathyroidism?

Authors:  Suk Hyun Lee; Eonwoo Shin; Sejin Ha; Jungsu S Oh; Dong Eun Song; Jin-Sook Ryu
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

5.  Utility of surgeon-performed pre-operative ultrasound in the localisation of parathyroid adenomas.

Authors:  Paul Rs Thomas; Andrew D Beggs; Thang S Han
Journal:  JRSM Cardiovasc Dis       Date:  2019-06-19

6.  Refractory hypercalcemia due to an ectopic mediastinal parathyroid gland in a hemodialysis patient: a case report.

Authors:  Yingjing Shen; Peipei Fei
Journal:  BMC Nephrol       Date:  2019-05-14       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.